Guggenheim Begins Xponential Health Inc (XPOF) at Purchase

0
637

(Updated – Aug 17, 2021 6:08 AM EDT)

Guggenheim analyst John Heinbockel starts reporting on Xponential Fitness Inc (NYSE: XPOF) with a buy rating and a price target of $ 16.00.

The analyst comments, “We’re starting reporting on Xponential Fitness, the only operator of a scaled portfolio of specialty fitness brands with a BUY rating and a PT of $ 16 reduced capacity but the presence of nine leading, however very different brands, each of which benefit from critical X-factors relating to studio openings, programming and operations, lays the foundation for a sustainable 15-20% secular Algo EBITDA multiple compared to the current 13-fold in our opinion. “

For a summary of analyst ratings and review history for Xponential Fitness Inc, click here. For more review news on Xponential Fitness Inc click here.

Xponential Fitness Inc’s shares closed at $ 11.80 yesterday.